Disclaimer: The transcript that follows has been generated using artificial intelligence. We strive to be as accurate as possible, but minor errors and slightly off timestamps may be present.

You can click the timestamp to jump to that time.

David Sinclair (00:00):

Welcome to the Lifespan Podcast, where we discuss the science of aging and how to be healthier at any stage of life. I’m David Sinclair. I’m a professor at Harvard Medical School. I run a research lab that studies aging, why we get old, and why we may not have to. I’ve been there for 20 years, and we’ve made some breakthroughs we’re going to talk about on this podcast. I’m also joined by my lovely co-host, Matt Laplante.

Matthew LaPlante (00:30):

Lovely. Talented. Brilliant.

David Sinclair (00:32):

Reasonably talented. Good looking. You’re a great writer. We co-wrote a book called Lifespan together. I’ll take that compliment. Thank you. And we’ve been really excited about the reception of this book, but we thought, why don’t we spread the word? Those of you who haven’t read the book, that’s fine. We’re going to go into detail in this episode to give you a basis for what we’re going to talk about in this series.

Matthew LaPlante (00:54):

And if you have read the book, that’s okay too, because so much has changed in the last three years since the book was published.

David Sinclair (01:03):

Right. So a little bit about you before we get too much into the weeds. You’re a writer. You used to be a reporter. You’ve been a war correspondent. What am I missing?

Matthew LaPlante (01:12):

I’m a professor of journalism at Utah State University. Right. It’s not Harvard University, but it’s pretty… It’s the Harvard University of the Mountain West.

David Sinclair (01:20):

Anyway, you’re brilliant at writing and I certainly couldn’t have written this book without you, but this podcast, we actually talk. We talk a lot every week. We’re writing another book, which will be due out, we hope, probably next year. Oh dear God. Yeah. Well, we’re going as fast as we can, but so Matt and I talk a lot and we have these conversations that are pretty funny. And anyone who overhears these conversations says that should be a podcast.

Matthew LaPlante (01:46):

They’re funny to us.

David Sinclair (01:47):

Well, we’ll see. They might be funny to other people, but the point is you bring out the best in me. You act like the caveman with the questions that I need to ask myself. And that’s what gave rise to lifespan. It was asking the questions that I didn’t even know I needed to answer.

Matthew LaPlante (02:05):

Well, and for me, that experience is like… And whenever I work with anybody on a book, but especially, I mean, for whatever reason, the way we’ve hit it off, like I feel coming away from these conversations that I’ve just gone through like a graduate course of study and this thing that I don’t have any personal expertise in. I didn’t go to school to do what you do, but I come away from these conversations and I feel like I’ve been in class in a really good way is I’m a lifelong learner. I love this, right? I’m a student right now. And that’s something that we can share with everyone.

David Sinclair (02:40):

Well, it sounds corny, but it really is a match made in heaven. You, before I met you, had written a book about epigenetics. We’re going to get into that. That’s key to understanding aging. You’d written a book about extreme animals. Your book, you want to plug it or…?

Matthew LaPlante (02:55):

Superlative The Biology of Extremes? Yes. You’ve got quite as many copies as Lifespan.

David Sinclair (03:02):

Well, so yeah, we should plug that. It’s a great book. It’s about animals that teach us how we can optimize our biology, something that’s going to be a topic of this series.

Matthew LaPlante (03:11):

Yeah. And in fact, we’re going to talk about that a little bit today as well.

David Sinclair (03:14):

Well, we are. The point of this series, let’s talk about why we’re doing this besides entertaining ourselves and others, is that we are at a turning point in medical history. We finally, as a species, understand how to control our biology, how to optimize our bodies during early life, midlife, and certainly late life to lead lives that can be decades longer and healthier.


And we want to share that information. It’s very hard for the average person to understand, let alone digest thousands of scientific papers. That’s what I do. I’m a team of researchers. In fact, today we’re supported by a team of researchers who have helped us gather information from around the scientific literature. My job and yours is to present that as a lesson to people who want to listen and learn beyond what they hear and can read on the internet, which is actually rather untrustworthy information. We want to be, I promise, to be a source of facts and information. When we give a study, people can look it up. If I don’t know something, we will make sure that we find the original source to that information so that you can trust. If we say something is a fact, it is definitely a fact. And we have no, we’re not selling anything. I’m not selling any supplement. So when I talk about supplements later, it’s based on facts. And we also, we promise to say whether it’s a study in a worm or a yeast cell or a mouse or a human, because that’s very important because otherwise people conflate a study in a mouse with a human study and there’s a big difference between a mouse and a human of course.

Matthew LaPlante (04:48):

All right, so we’re going to do this for eight episodes. Today’s episode is Why We Age. We’re going to dive into that in a second here, but let’s give a real brief overview of where we’re going from here.

David Sinclair (04:59):

Well, the reason for doing this podcast really is that we are living in a really important moment in medical history, I think as big as antibiotics and vaccines. We are going to be able to live decades longer with signs that’s coming out every week that’s making my head spin. I want to bring that to the public and provide actionable information. What people can do in their daily lives starting today to ensure that they live well now and decades into the future, not just living longer, but living much better as well.

Matthew LaPlante (05:30):

And this includes for low and no cost at all. These are things people can actually implement in their lives right now.

David Sinclair (05:35):

Right, so future episodes include not just what to eat, but when to eat, and actually packing meals into shorter periods of time will ultimately save money. It’s not expensive at all, and some of the supplements we’ll talk about and treatments and even medicines are relatively cheap. So this isn’t for billionaires, though there are plenty of billionaires we can talk about that are into this. These are things that we can implement right now. And that’s the exciting part. I want to talk about the science behind that, because right now people are confused. What should I eat? When should I eat? Should I eat meat? Should I eat vegetables? We’re going to go through all that in coming episodes. We’re even going to talk about-

Matthew LaPlante (06:15):

It’s not just eating, it’s how we should exercise when we should exercise. Of course. Right, we’re going to have an episode on that, about how we should stress our bodies.

David Sinclair (06:24):

Stress is important. So a little bit of stress on the body puts it into this defensive mode. We’re going to talk about this concept of hormesis in future episodes. We’re going to dive in in detail and say, all right, there’s this study that shows that if you exercise this amount, you get this much longevity. If you eat this, you get this much longevity. There’s also some more exotic things. There’s cold therapy, there’s heat therapy, there’s peptides, there’s things called exosomes. We’re going to go right to the cutting edge of science and maybe a little bit beyond to see what’s coming in the future, including age reversal, a new concept in this field as well.

Matthew LaPlante (06:57):

This episode though, our deep dive today is aging. Why aging happens?

David Sinclair (07:03):

It is. We want to provide the fundamental understanding of what the biology is that tells us why we age and ultimately why we don’t have to.

Matthew LaPlante (07:12):

Before we get into that, David, I know you want to talk about our sponsors because that’s what actually makes this possible and makes it so that anybody can access this at any time they don’t have to pay for it.

David Sinclair (07:23):

Well, exactly. What we’re doing today is separate from my work at Harvard, of course. And what’s exciting about it is we can also mention sponsors who I truly believe in. Our first sponsor is Athletic Greens. Athletic Greens is an all-in-one daily greens drink that supports better health and peak performance. It’s developed from a complex blend of 75 vitamins, minerals, and whole food-sourced ingredients. It’s filled with adaptogens for recovery, probiotics, prebiotics, and digestive enzymes for gut health, as well as vitamin C and zinc for immune support. I’ve been drinking Athletic Greens every morning, pretty much for the last few years, and this is a way that I can cover all my nutritional bases.


I’m often traveling, sometimes my diet isn’t the best. And so by drinking Athletic Greens, I know I’m getting the vitamins and minerals that I need to stay healthy. If you’d like to try Athletic Greens, you should go to slash Sinclair, and you can claim a special offer. They’re giving five free travel packs plus a year’s supply of vitamin D3 for immune support plus vitamin K2. K2 is really important to make sure the calcium in your body doesn’t go into your arteries where it doesn’t belong and put it into your bones where it does. Again, go to slash Sinclair to claim this special offer.


Today’s podcast is also brought to us by Inside Tracker. Inside Tracker is a personalized nutrition platform that analyzes data from your blood and DNA to help you better understand your body and reach your health goals. I’ve been using Inside Tracker for over a decade, and I’m the chair of their scientific advisory board. The reason I’ve long used Inside Tracker is because they provide the best blood and DNA analysis that I know of.


They make it easy to get your blood drawn. You can either go to a local clinic or have someone come to your home, like I have done, and it only takes 15 minutes. And from there, Inside Tracker presents your blood analysis in a really easy to understand way. There are graphs and they give you diet and lifestyle recommendations, and these improve your blood biomarkers. Another feature that Inside Tracker has that I really like is their inner age test. I actually helped develop it.


This test shows you what your biological age is, how it compares to your chronological age, and what you can do to improve it. So if you’d like to try Inside Tracker, you should visit them at slash Sinclair and you’ll get 25% off any of their Inside Tracker plans. Use the code Sinclair, my last name, at the checkout. Today’s episode is also brought to us by Levels. Levels is an app that syncs with a continuous glucose monitor, which they provide, and interprets your glucose data for you. I’ve been so impressed by Levels that I recently joined the company as an advisor. By monitoring your blood glucose, Levels allows you to see how different foods impact you. I’ve had a lot of fun running tests of my own, seeing how different foods impact my blood glucose levels.


For example, I’ve learned that white rice and grapes really spike my blood sugar, whereas potatoes don’t. As we’ve discussed on this podcast, having stable blood glucose is very important, not only for daily mental and physical energy, but also for long-term health. So if you would like to try Levels, you can skip the 150,000-person wait list and jump the line to join today by going to slash Sinclair. That’s slash Sinclair.

Matthew LaPlante (10:45):

David, the research in this space is moving really fast right now. It’s hard to keep up with. It’s hard even for you to keep up with sometimes, right?

David Sinclair (10:57):

Well, it is. I read scientific papers even before I get out of bed, so I’m here to collate that and present it. But there’s so many publications that come out every week that it’s making my head spin. And the technology that’s being developed, we can do a million experiments that used to take, each one used to take a year when I started in this field.

Matthew LaPlante (11:17):

And so that’s just allowing publications to just flourish right now in this area. It’s allowing researchers to do a lot more work in a shorter amount of time. The result is that there’s a lot to go through.

David Sinclair (11:32):

Well, there is, and it’s coming out every week. And so the goal here is to keep everybody up to speed on what the latest discoveries, technology, and what they can apply to their lives as we’re learning this almost on a daily basis.

Matthew LaPlante (11:46):

And this is the Lifespan podcast, but if you haven’t read Lifespan, it’s okay, right?

David Sinclair (11:53):

We’re going to get you up to speed.

Matthew LaPlante (11:55):

If you haven’t read Lifespan, you should read Lifespan. You don’t have to pause the video right now though.

David Sinclair (12:02):

Right. We’re going to give everybody a primer on what’s in Lifespan. And if you’ve read the book, great, we’re going to go over the major topics so that everybody is with us as we go forward with these other seven episodes.

Matthew LaPlante (12:14):

And even if you’ve read the book, there’s more information. I mean, there’s been a couple of years since the book was published.

David Sinclair (12:18):

Oh yeah, we’re light years ahead of where we were in Lifespan. There’s a lot to talk about, including things that you can apply in your daily lives that we didn’t know when Lifespan was written.

Matthew LaPlante (12:28):

One of the misconceptions I think a lot of people have about the book, a lot of people have about your research is they think that you’re trying to prevent old age. Well, we are, but that’s not the only thing. Because what we’re talking about really is preventing aging and that doesn’t just happen when we are old.

David Sinclair (12:45):

Of course not. In fact, it happens over your entire Lifespan, even before you’re born.

Matthew LaPlante (12:50):

So we’re going to get into exactly how we know that. But this is fascinating. This is a fascinating area of research. There’s been recent studies on this, which can actually measure in utero an infant’s age.

David Sinclair (13:02):

Yeah. In fact, when we’re young, we’re aging faster than when we’re old. But we’ll talk about that clock later. But what’s important here is that we can improve our health and our long-term survival at any age. And we’re going to talk about those lessons and what people can do at any age to improve their chances of being healthy later in life, as well as look good and function optimally now.

Matthew LaPlante (13:23):

All right. There’s a lot of misconceptions about what aging is. I think in no small part that comes from the conflation of aging with years lived. That makes sense for most of our human history because people got old when they were older, or at least as we conceptualize it older. But the other thing that people have long assumed is that aging is inevitable. It’s just going to happen to all of us. You have argued to me, and I think I believe you. This is not the case.

David Sinclair (14:01):

Right. In my lab now, we can control aging very precisely at will. We can speed it up as fast as we want in an animal and even reverse it. So aging is now controllable. It’s in, we have the technology to control how fast we age. We can measure that, slow it down and even reverse it. This has never happened in human history before. And one of the reasons that we’re doing this today is to make sure everybody knows that this is coming because it’s going to fundamentally change the course of human history.

Matthew LaPlante (14:28):

This is something that perhaps shouldn’t have come as such a shock to us because in fact, if you look across the animal kingdom, there are all kinds of animals that age at different speeds, at different rates, even though the, as we’ll get into, the root source of aging is the same for everything. We age at different rates.

David Sinclair (14:52):

We do. And sometimes I’m criticized because I’ve been on record. I am on record saying the first person to make it to 150 years of age has already been born. And people say, how can you say that? Well, it gives you confidence that we can even live five years longer. Well, there are, if we look at the animal kingdom, first of all, there are plenty of species that live that long. There is no reason why we can’t do what they do. And if we learn how they do it, we can apply that to ourselves.

Matthew LaPlante (15:18):

So one of these animals that I know you’re, you’re sort of fascinated by right now. In fact, there’s a picture of them on your computer screen right now. You’re, one of your children works on these.

David Sinclair (15:28):

Yeah. Morats. Alex, our oldest child. Yeah. These naked mole rats. They’re fascinating. They, they’re weird looking. They’ve got sharp teeth and the rest of the body is long. It looks like a condom filled with walnuts actually. Yeah, they’re really weird, but what’s exciting to, to work on them. And Vera Gorbinova is the professor that Alex works with. They found that these animals have particular traits biologically, molecularly that allow them to live decades longer than a typical rodent, which mice live a bit over two years, rats over four years.

Matthew LaPlante (16:02):

But these are similar animals and one lives, how long does a mole rat live?

David Sinclair (16:07):

Over 30 years.

Matthew LaPlante (16:08):

Over 30 years. And then normal rodents or other rodents, most rodents live a few, right?

David Sinclair (16:13):

Right. And what’s important to realize is that there’s a, there’s a reason why that is animals that don’t have a lot of predation, whales, mollusks, sharks, mole rats underground, they, they don’t get eaten. So they can put their energy into building a long lasting body. And actually as, as a consequence, they reproduce slowly as well. But what’s important is that you can build a longer lived body and we can do that too. We can engineer ourselves. We can learn from these animals by studying what makes them live so long.

Matthew LaPlante (16:43):

Well, you just named some of the pretty well-known sort of longevity species. Can we get into that? Can we talk about what makes each of these animals survive for so long?

David Sinclair (16:55):

Right. We can learn a lot. In fact, we should also talk about the bristlecone pine, which was a species you were going to look at when I first met you, before we wrote the book.

Matthew LaPlante (17:03):

I was, I was in the White Mountains, actually the first time you called me ever, I was up on my way to go see the bristlecone pines in the White Mountains.

David Sinclair (17:11):

Right. And so these, how long do they live?

Matthew LaPlante (17:13):

Like 5,000 years. It’s an absolutely amazing.

David Sinclair (17:15):

That’s incredible that they were old when Jesus was born. They were. Yeah. Yeah. And so what we can learn from those species is that you don’t have to get old.

Matthew LaPlante (17:25):

Okay. But there’s a big, big difference between a bristlecone pine and a human being. Or a naked mole rat for that matter. I mean, like it’s.

David Sinclair (17:32):

Right? Really? No, no. We’re all built from the same stuff. We’ve got DNA, proteins, RNA. We can engineer ourselves to be that long-lived. If we didn’t have predation for the next 10 million years, we would live for centuries. We just don’t have time to wait for evolution to take hold. We can engineer ourselves the way evolution would make us live longer.

Matthew LaPlante (17:53):

One of the interesting things about bristlecone pines, and you see this, if you go anywhere where these amazing, like gnarly trees are, and they really are, I mean, like they don’t even, they actually don’t really even look like they’re living a lot of times. And they live in these incredibly adverse environments. And that’s, that’s characteristic of a lot of long-lived species. Is that, is that, is there a clue there?

David Sinclair (18:14):

Well the species that don’t have a lot of predation live a long time. But also in these extreme environments, they’re turning on their body’s defenses against aging. And we can do that to ourselves. It’s a concept called hormesis. And again, we’ll get to that in other episodes. But adversity, as long as it doesn’t hurt your body, will make you healthier and live long.

Matthew LaPlante (18:33):

Okay. And I do take your point that, I mean, there’s vast similarities across all living organisms. But I do think also it’s hard to make the argument that a tree is, you know, something that we can learn from. But we don’t need to even make that argument because there are these other organisms, right, going I mean, from sort of like a bristlecone pine, which is a plant, to a sponge, which is an animal, to a mollusk, which is an animal, to a whale, which is a mammal. And we’re getting closer and closer to humans. And across all of these categories, we’ve got organisms that have learned how to live a lot longer than we do.

David Sinclair (19:13):

Right. Well, we’re essentially upright whales. That sounds crazy, but at the molecular level, if you look at the biochemistry, we’re only separated by 40 million years, which is a blink of an eye in geological time. We actually could live as long as whales. There’s not that much difference between us.

Matthew LaPlante (19:30):

And a whale lives, we know bowhead whales can live for hundreds of years, more than 200 years.

David Sinclair (19:37):

Right. Well, yeah, and they know that how?

Matthew LaPlante (19:38):

They know that because, well, for a number of reasons, there’s actually been some really cool studies on this, but one of the reasons is that they dated a harpoon that was stuck in a bowhead whale for 200 years and the whale was still living when they pulled it out of the whale. Well, I think they whaled it, but.

David Sinclair (19:58):

Yeah. Well, that, what’s interesting is you can, we now have the genome of these animals and we can see that they have multiple copies of what we call longevity genes. Some of which we discovered when I was in my twenties, these are genes that protect the body. Longevity genes actually get turned on by adversity and there are ways we can tweak them, but whales naturally have multiple copies and higher levels of these longevity protective mechanisms. And the bristlecone pine has just whopping amounts. The problem.

Matthew LaPlante (20:27):

And that’s that connection that you’re making there. You’re like, oh, look, we see this in a bristlecone pine, we see this in a whale and oh, by the way, this gene also exists in humans.

David Sinclair (20:35):

Yeah. We’re not that different from a banana, actually. Genomes are 40%. You’re not that different from banana. Well, I’m not going to go there, Matt, but the important thing is that when you study other organisms, whether it’s a banana or a yeast cell or a worm or a fly, we can learn lessons about biology and especially about aging. We can learn more about aging from a yeast cell than we can about Alzheimer’s or cancer.

Matthew LaPlante (20:59):

This is why you’re dismissive about people’s dismissiveness about like only in mice. When people say, oh, we discovered this and people go, oh, only in mice, there’s a lot we can learn from mice.

David Sinclair (21:10):

Well, we can. And aging is one of these universal things. And what really is remarkable that we’ve learned in my lab over the last 20 years is that the same genes that control aging in yeast work in worms and flies, mice, and even humans. That’s a big deal. We didn’t know that 30 years ago. Now we know that there’s a fundamental set of genes that controls how fast we live. And then we can also exploit that to slow down our own aging now. And as we’ll get to later, we can use that knowledge to even reverse the aging process.

Matthew LaPlante (21:43):

We’re talking about these genes. Let’s name some of these genes.

David Sinclair (21:47):

Right. Well, so there are various categories. There are hundreds of longevity genes that are known, but they fall into three main buckets. The first one is called mTOR. It’s a little m for mammal and TOR, target of rapamycin. So mTOR is a longevity gene that makes a protein that senses amino acid. So when you eat a big steak, mTOR activity actually is activated and mTOR now says, okay, I’ve got lots of protein. I’m going to make muscle. I’m going to burn energy. And that’s why when you eat a steak, you actually, you build up muscle more than if you don’t eat a lot of protein.

Matthew LaPlante (22:22):

Is that a good thing?

David Sinclair (22:23):

No, it’s actually not. What you want is to have mTOR levels low to inhibit the mTOR. And when you have low mTOR activity, that’s when you get the longest lifespan. Mice that are given a drug called rapamycin, which is used to suppress the immune system in patients, but you can take low doses as a human or give it in low doses to a mouse. Those mice live dramatically longer. Even if you give them rapamycin when they’re 20 months of age, which is a really old mouse, that’d be like a 75 year old human, they still live longer. So low activity of mTOR is a signal that times are tough.


You don’t have enough food, hunker down, build a stronger body, survive. And the outcome of that is longer life for these mice. But it turns out it’s not just for mice. You give rapamycin to a yeast cell or a fly or a worm. They also live longer. So you can tap in with these drugs into this universal longevity program, one of which is mTOR.

Matthew LaPlante (23:19):

And so you have a colleague, a long-term colleague who’s been working on mTOR for a really long time. I know you’re really impressed with their work.

David Sinclair (23:26):

I think you’re referring to Matt Kaeberlein? Yeah. Yeah. So he’s doing great work. What’s fascinating is he’s treating dogs with rapamycin and showing that it protects their heart and he’s also going to test their lifespan.

Matthew LaPlante (23:39):

And we’re seeing in dogs what we saw in yeast, in mice, and the rapamycin works, you know, this target of rapamycin, this gene, influenced in a certain way, works the same way across species.

David Sinclair (23:52):

Right. And that’s why I think solving aging is going to be easier than solving cancer and heart disease because aging is fundamentally conserved. We can make rapid progress extending the lifespan of little yeast cells, worms with chemicals, and then put them into humans. And hopefully we’ll see they’ll work the same way like rapamycin seems to do and other molecules that we’re going to get to in later episodes. But the point here is that aging is not that complicated once you understand the genes that control it and then the fundamental causes of aging as well.

Matthew LaPlante (24:21):

And you just said genes that control it. So we talked about mTOR, but there are other genes that control it and we’re going to see similar things in each of these genes. What do you want to talk about next after mTOR?

David Sinclair (24:29):

Let’s do bucket two. Okay. Bucket two is AMPK. It’s called AMP activated kinase. So what is AMPK? It sounds like the name of a punk band.

Matthew LaPlante (24:40):

That’d be a great name. Ladies and gentlemen, it’s AMPK.

David Sinclair (24:44):

And in this case, we don’t want less of it. We want more of it. We want to activate AMPK. So how do you do that? Uh, you actually, you eat less, you fast and that’ll turn on AMPK. It’ll do a few things. It’ll make your body more sensitive to your insulin, suck the sugar out of your bloodstream, which can be toxic if it stays high, but it also ramps up the energy producing centers of the body. These membrane filled bags, which are actually ancient bacteria living in our bodies called mitochondria.

Matthew LaPlante (25:13):

Who’s doing the cool work in AMP, AQ, RST, AMPK, who’s doing the cool work in AMPK right now?

David Sinclair (25:20):

Well, it’s been studied by thousands of labs, but the, the one that’s most interesting I think right now is to see if a drug that activates AMPK extends human lifespan, slows down aging. And that’s near Barzilai, my good friend out down in New York at Albert Einstein College of Medicine.

Matthew LaPlante (25:36):

And the drug is metformin, which is, uh, most people would know as a diabetes drug.

David Sinclair (25:41):

Yeah, metformin is really interesting because it’s super safe. It’s one of the safest drugs ever known. It’s on the World Health Organization’s list of essential medicines for humanity. In much of the world, it’s, it’s cost pennies and you can get it over the counter. They’re paying you to take it. Essentially they want it. In those countries, they just want you to have it like aspirin. In the U.S. and a lot of English speaking countries, uh, in Europe, you need a prescription for this drug. And it’s the frontline therapy for type 2 diabetes or high blood sugar.

Matthew LaPlante (26:10):

And there are, there is an active ongoing human trial of metformin called Targeting Aging with Metformin, right? The TAME study?

David Sinclair (26:19):

The TAME study. Yeah. Yeah. Um, so why do we think that metformin actually works? Well, first is we, my lab in collaboration with Rafael de Cabo down at the National Institute on Aging showed in a mouse study that if you give them metformin, those mice are healthier and live longer. Again, it doesn’t prove that it works in humans, but you can take tens of thousands and people have taken tens of thousands of people who are on metformin for type 2 diabetes and looked at their overall health and their lifespan. And this fact that I’ll tell you blows my mind. Type 2 diabetics that go on metformin on average live longer than people that don’t have type 2 diabetes.


And they’re protected against diseases. So if you’re susceptible to cancer or heart disease frailty, those on metformin reduce their risk of those diseases. Whereas those that don’t take metformin, it increases over time.

Matthew LaPlante (27:06):

Okay. Why does NEAR think that this is happening? Like at the molecular level, what’s going on?

David Sinclair (27:12):

Well, AMPK is a sensor of energy and low energy is a good thing for longevity. It’s one of the reasons I fast. We’ll get into that in a future episode, but AMPK is central to sensing low energy. And in response, it protects the body because it’s thinking we’re going to run out of food.


So this is another evidence of this term, hormesis. What doesn’t kill you makes you stronger. And AMPK sits as a central regulator of the body’s defenses. It will downregulate mTOR. It will activate other longevity genes. And that’s really important. Genes are working in concert with one another. That’s a really important concept because about a decade ago, scientists like me, we were fighting over whose longevity gene was more important. It was pretty pathetic.

Matthew LaPlante (27:56):

And very typical of scientists.

David Sinclair (27:58):

Right. Everyone wants to be the smartest person in the room. But what we finally realized 10 years ago is that these genes talk to each other and they’re part of a network, which actually is a blessing and a curse because you can tweak one and affect the others. But now we’re faced with now what? Which one is best to tweak? And if you tweak two out of three or three out of three, is that good or is it bad? And that we’ll get to also in later episodes.

Matthew LaPlante (28:25):

Well, and okay, so you said three now. So I’m hearing some similar things though, and I think this is really important. One of which is that in these genes are activated by stress. mTOR is, AM, gosh darn it, AMPK is, and the gene that you work on, that you’ve been working on for a really long time is as well.

David Sinclair (28:48):

Well it’s a family of genes. We have seven of these, what we call sirtuins.


And we linked them to aging when I was a postdoc at MIT back in the 1990s. And what we’re looking at as a group was what can make yeast cells live longer? And there was one mutation that led us to a gene called SIR2, S-I-R-2, which stands for silent information regulator number two. And information is the key, but we’ll get to that later. But this set of sirtuin genes, this family, has been shown in yeast and worms and flies, mice and now humans to be a really important central regulator of longevity. We showed, now going back to 2005, that fasting activates the sirtuins, and later we showed exercise activates these genes. So a lot of the things that we’re told by doctors to do to live longer and be healthier, we think acts through the sirtuins in concert with these other two sets of genes we just talked about.

Matthew LaPlante (29:50):

You know, I really appreciate about this because I think there’s a lot of like bagging on doctors right now. It’s like they never tell us the same thing. They never tell us the same thing, but they’ve always told us diet and exercise. And maybe like the individualized device is a little different, or maybe it’s shifted a little bit, but it’s like, eat better, work out. And that’s what helps activate the sirtuin to do what they do.

David Sinclair (30:11):

And it’s an important concept because most people think, oh, when you run, your blood flows and clears out your arteries and when you eat less, it’s just good for you. But that’s not what’s happening. Well, right. What we’ve discovered is that these longevity genes, these three sets we’ve just mentioned, need to be either down-regulated or up-regulated in a certain way. How do you do that? These lifestyles, certain types of diet, when you eat and exercise, essentially you want to trick your body into thinking that it’s under threat of survival, adversity. You don’t want it too much. You don’t want to damage your body so that it can actually have the opposite effect, but you want to give it a little bit of fear and it will have great results and give you payback for decades to come.

Matthew LaPlante (30:57):

Okay, so I know we’ve talked about these other two longevity genes, but I really want, because you’re the sirtuin guy, I want to dive a little deeper into what’s making these things tick. And this gets a little complicated. It’s a little down in the weedish, but it’s important as we get to the information theory of aging and this idea that we’re going to be driving toward in a minute here, which is X differentiation. So can we talk a little bit about why the sirtuins are doing what they’re doing and how that works at the genetic level? Right.

David Sinclair (31:34):

All right. Well, let’s do a little bit of biology. Some people haven’t had a biology lesson in decades. It’s been a long time. Yeah. So let’s start with a cell. Cell is a microscopic bag of fluid packed with proteins. The proteins are encoded by the DNA, which is in a part of the cell called the nucleus. So let’s become microscopic. Let’s dive down into a cell and have a look what’s there. So first of all, we pierce the outer membrane. There are a lot of proteins on the surface that bring in things like sugar and amino acids that are important. Now we’re swimming around and we can see there’s another little structure that is surrounded by a membrane called the nucleus. So let’s go through there. There are little pores we can swim through.

Matthew LaPlante (32:13):

This is what we remember from middle school biology is the brain of the cell.

David Sinclair (32:17):

It is the information, the genetic information of the cell encoded in a six foot long strand of a chemical called DNA.

Matthew LaPlante (32:26):

This is six feet of DNA in this little microscopic. You can’t even see it.

David Sinclair (32:32):

There’s so much of it in the body, it stretches from here to the moon and back eight times and it all has to be packed into very small space. And so you don’t just, the cell doesn’t just shove this strand willy nilly into this structure. It’s not like me packing to go travel. It’s actually neatly packed. And the way the cell does that is that it wraps the DNA around proteins called histones and those histones then attract each other and eventually get these structures we call chromosomes, which you can see sometimes with your eyes, but usually with a microscope. But it doesn’t all get bundled, otherwise no genes could be read. Some of the genes have to be opened up and unraveled, unspooled so that they can be turned on.

Matthew LaPlante (33:12):

It is a really good analogy for this if you existed during the 1970s and 1980s when cassette tapes were a thing.

David Sinclair (33:22):

You might want to describe what they were.

Matthew LaPlante (33:24):

Okay, so having existed in these times, so for the children at home, a cassette tape is a plastic cassette with a reel on either side of magnetic tape. But the important thing here for this analogy is that if you turn it on its side, only a little bit of that tape, that tape includes a lot of information, but only a little bit is readable at any given time. And that would be a gene. And that would be a gene. And so if your cell is trying to read your code, it’s accessing just that little bit at a time. It’s not accessing all of it. And that’s actually what helps cells know to be cells, or the kind of cells they are.

David Sinclair (34:06):

Well, it’s essential. When we’re fertilized as an egg, we can be anything, but we need to have certain cell types. A brain cell has to know how to be a brain cell for 100 or more years, and a liver cell has to stay a liver cell. So if you wake up tomorrow and your brain is more like a skin cell, you’re in trouble. So what happens is that the packaging of the DNA is specific to the cell type. And every time that cell divides, like in a skin cell, it doesn’t suddenly become a neuron because the cells inherit the information that says that gene is for skin cells and keep that one on, but don’t turn on the brain cell.

Matthew LaPlante (34:38):

And they know this through epigenetics.

David Sinclair (34:41):

Epigenetics is the other part of the information in a cell that controls which genes are packaged tightly or unfurled or unspooled, like can happen if your cassette tape gets stuck in the machine. You remember when that used to happen?

Matthew LaPlante (34:54):

I do. And then you’d have to take the little pencil and wind it up.

David Sinclair (34:56):

Yeah, exactly. That’s part of the problem with aging, we think, is that that beautiful packaging of the DNA that allows a cell to remain a skin cell forever or brain cell essentially forever is lost. You start to get this unspooling of the DNA and genes that shouldn’t be on start to come on over time.

Matthew LaPlante (35:17):

Genes that shouldn’t be readable are now readable. And so you have like all this extra information floating out there that the cells can read. And because the cells are now reading large parts of the code instead of the very specific parts of the code, they get confused?

David Sinclair (35:32):

Right. And we call it X differentiation. Differentiation is the common term for cells becoming a certain cell type. And we’ve coined the term X differentiation, which is essentially cellular confusion. They become a more of a generalized cell type rather than a specific one because genes that shouldn’t be on start to come on over time. And that we think is a root cause, if not the root cause of aging itself.

Matthew LaPlante (35:57):

Let’s unpack that a little bit. Excuse the pun. Because, oh yeah, it is kind of a pun. The thing that you’ve told me and that really just like sort of completely shifted the way that I was thinking about aging, even after actually working with you for quite a bit, is that this is not just the root cause of aging. You believe that X differentiation is the root cause of many, if not most diseases?

David Sinclair (36:32):

I don’t just believe it. I think it’s now a fact. When you look at Alzheimer’s disease, and unfortunately up until the last few years, we were treating it at the end stage of the process of aging, which results in plaques and tangles and dementia. But the process that led to that disease was happening from birth, and that’s aging. So Alzheimer’s, just to take one example, is an age-related disease that’s not just age-related. It’s actually 90% of it is caused by the aging process, this unspooling, this X differentiation.


If we were able to slow that down, you’d have Alzheimer’s much later. And now we’re showing in my lab, and we’ll talk more about this, but I want to mention it because it’s so profound. We can reverse the age of a brain in an animal. And when we do that, we’re showing, and we will continue to test this, that those diseases go away, proving that those diseases are actually caused by aging.

Matthew LaPlante (37:29):

Okay. So let me see if I can put this into sort of some kind of a picture. We have these brain cells. Neurons, yeah. Neurons. We have neurons. Over time, because our DNA unspools, it becomes less tightly packed, the code is more readable. For instance, the code that makes a liver a liver or a kidney a kidney. And so that brain cell is sort of also part kidney cell.

David Sinclair (38:02):

Right. And we can read all the, which genes are on. We call it gene expression patterns. It’s very easy.

Matthew LaPlante (38:08):

So you see, you actually see this in, in Alzheimer’s brains. You can see that the cell is losing its identity.

David Sinclair (38:14):

Losing its identity. Right. Losing its mind, so to speak. And we can see that with normal aging too. Even if you don’t have Alzheimer’s during aging, I’m 50 now. So some of my brain cells are undoubtedly getting confused and starting to believe that they’re part skin cell, part kidney cell. And that’s probably the reason why even in your fifties, you cannot function like you did in when you were 20.

Matthew LaPlante (38:35):

Okay. That’s dementia. That’s Alzheimer’s. What about other diseases? There’s another one. That’s a good example for this type type two diabetes. Right. High blood sugar. High blood sugar. Same process. Yeah. Same problem. Well, it is.

David Sinclair (38:51):

These aren’t two different diseases. Same thing. That’s a major point that we’ve been looking at diseases as separate things. This is how modern medicine works. We need a different drug for type two diabetes right now and for Alzheimer’s, for cancer, for frailty, muscle wasting, bone loss. I’m saying that the same process is leading to all of these diseases. And if we can slow down and even now we have the technology to reverse that process, those diseases will be slowed down and even go away by age reversal.

Matthew LaPlante (39:21):

Okay. I’m, I’m, I’m on the cusp of this. I want you to spell it out for me though with the diabetes. And then I want you to do like, I like things in triplicate. So I’m, I’m convinced on the Alzheimer’s explain what’s happening in the diabetes that makes it the same process.

David Sinclair (39:35):

Yeah. Well, so type two diabetes in part is a problem of bringing glucose sugar out of the bloodstream into your muscles in your brain, which are the major sources of, of a major requirement is glucose. And if you don’t suck the sugar out of your bloodstream, you’re going to have basically treacle or caramelized protein in your system, which is going to cause all sorts of, no, you don’t want to have glucose attached to proteins. In fact, you can measure it. Doctors when they do a test called HBA1C, that really means how much glucose is physically bound to your hemoglobin, which carries your oxygen. And it’s a percentage. So if you have over 5.7% of your hemoglobin attached to glucose, you’re prediabetic. And over 6.5, I believe the number is that you’re actually type two diabetic at that point. And then you go on metformin. The point being is that having high levels of blood sugar we know predisposes you to other diseases, heart disease, frailty, dementia, you don’t want to have a lot of sugar in your blood. It’s one of the reasons for keeping my, I believe everybody should try to keep their blood sugar levels reasonably low because the higher levels are toxic. But what’s happening in terms of the aging process, one of them is that the cells that line the blood vessels that suck the glucose out of your system are losing their function. There’s a particular gene that’s required to suck glucose through the cell from outside in, it’s called GLUT4. It’s a glucose transporter number four. And over time with aging, and particularly if you’re obese and you don’t exercise and don’t do all the good things, your cells lose the ability to make that GLUT4 transporter and glucose will stay in your bloodstream for longer, which is toxic.

Matthew LaPlante (41:22):

You just said just a couple of moments ago, you said, and then you take metformin and it occurs to me that we’ve got this metformin, it activates AMPK. So is it un-x-differentiating? What is it doing?

David Sinclair (41:37):

Well these defensive genes seem to partially reset aging. Sirtuins are part of the spooling process that with that cassette tape, they bundle the DNA. So by activating these various longevity genes, we’re slowing down and reversing some aspects of that x-differentiation process and getting the cells to remember how to behave.

Matthew LaPlante (41:57):

We did Alzheimer’s, type two diabetes, heart disease. This is, heart disease is cholesterol and bad food and a lifetime of bad exercise habits, right? But you’re about to tell me it’s not any of that. It is that, but it’s not that. It’s actually x-differentiation. Yeah, yeah.

David Sinclair (42:20):

This is what we find is that we can actually now control aging forwards and backwards in mice at least. And we’re doing experiments, clinical trials in humans now.

Matthew LaPlante (42:31):

Why do you do the clinical trials?

David Sinclair (42:32):

Well I mean… They’re not real trials. Well experiments in humans sounds bad, but clinical trials is the real…

Matthew LaPlante (42:39):

People are going to take that little section of tape and be like, see, he doesn’t really think they’re clinical trials.

David Sinclair (42:45):

Well these are all double blind placebo controlled clinical trials in humans.

Matthew LaPlante (42:49):

But in mice… Oh, that’s real.

David Sinclair (42:51):

So heart disease, what we’ve shown in my lab is because we can drive aging forwards by disrupting the spools, we can either reduce the amount of sirtuins, which causes them to spool out and x-differentiate, or we can create certain types of stress on the cell that caused that problem as well, extreme stress, not the hermetic type. We can accelerate aging in a mouse. And one of the effects we get is heart disease in a mouse. And so then we have this, now we have this evidence that disrupting the epigenome, the readers of the DNA causing x-differentiation is causing all of these diseases, including heart disease in the mouse.

Matthew LaPlante (43:30):

Accelerating aging in a mouse requires us to be able to measure aging. One of the ways that we can do that, and probably the one that makes the most sense to people in the way that we think about aging is you just look at a mouse, right? It’s got more gray hair, it’s becoming weaker, it gets confused, right? It’s not as perky and excited and it doesn’t run on its little treadmill as long. But there are now other ways that we can measure aging. And this is a really important point. This leads to the explosion.

David Sinclair (44:07):

Yeah, right. So it was 2013, a paper came out from Steve Horvath’s lab and there was another paper by Greg Hannam that showed that if you measure the chemicals that are controlling this bundling and spooling of the genome to specify cell type, there are certain sites on the genes that you can measure. The chemical is specifically called DNA methylation. It’s very simple. It’s just a carbon with three hydrogens. This chemical cells add to the DNA, stick to the DNA as you’re developing in the womb to make a brain cell different than a liver cell, different pattern.


But over time, there are changes that are predictable and they change in a linear fashion so that if I took your skin cell or your blood and I measured the DNA methylation pattern across the genome, across that six feet in one cell or in thousands of cells, which is how we do it, I can then plug that into a program and it’ll spit out your actual biological age, not your birthday candles, which is based on how many times the earth has gone around the sun. That’s irrelevant. It’s how old you really are, which can predict also when you’re going to die. That’s terrifying.


No, it’s not. It’s liberating because we know now how to slow that process down and even reverse it. We can get the DNA to spool less and also be repackaged to reverse the aging process and get cells to work like they used to. So that number shouldn’t be scary. It might be scary if there’s nothing you can do about it, but as we’ll learn in this series, there are plenty of things you can do about it.

Matthew LaPlante (45:45):

All this is well and good if we can all have our biological clocks measured at any time, but this sounds really expensive and time consuming and it’s a process. And I’m of course, teeing you up here, but this is also a really important moment.

David Sinclair (46:03):

Well, it used to be expensive just to read. The first human genome was more than $2 billion and took an army of people and whole buildings. Now we can read a genome on a Snickers size bar in a day. It’s going to be $100 probably next year. And we use that same technology to read the DNA methylation patterns. We put it through what’s called a DNA sequencer. And right now it’s a few hundred dollars to run your sample, which is still beyond most people if you want to do it every week or even every month.


But we’ve now, as a student in my lab, Patrick Griffin, who has just put up online our pre-publication that shows that we can pull thousands of people’s samples together and run them as one in these sequencing machines. That brings the cost down to about less than a dollar to run this. Why is that important? It means that one day anybody can do a cheek swab and determine their biological age and figure out whether what they’re doing in their life is working or not to slow down aging.

Matthew LaPlante (47:04):

So theoretically, if I wanted to check my biological age every week, I could do that for 50 bucks a year, essentially.

David Sinclair (47:12):

Exactly. And eventually it’ll be a little home device. You can do it every morning if you feel like.

Matthew LaPlante (47:16):

And your argument is, and I totally, I’m on board with this too. This is far, far more important to our understanding of our general sense of health and our general state of propensity for disease than our chronological age ever was.

David Sinclair (47:35):

Right. And we find that people who haven’t done the right things, who haven’t exercised and haven’t maintained a good diet, have an older biological age and will die sooner because of it. We can now measure the aging process with accuracy, which is, it blows my mind that we now have our biological credit score, which we can, by the way, we can alter. Aging is malleable. That number doesn’t stay the same and it doesn’t have to continue to tick up every year.

Matthew LaPlante (48:03):

In yeast, in mice?

David Sinclair (48:04):

Well, and in humans now, there are publications. Greg Fahey, who’s got a company out in California, worked with UCLA researchers. In fact, the guy that co-invented the clock, Steve Horvath. They published last year that a triple treatment of chemicals, I’ll name them, DHEA, metformin and growth hormone. It rebuilt the thymus, which is something that happens to all of us. It gets smaller, but more importantly, they measured the blood biological clock to figure out what happened to their age and they got younger by two and a half years. After one treatment? It took a month of treatment.

Matthew LaPlante (48:42):

Series of treatments. One series of treatments.

David Sinclair (48:45):

Yeah. But here’s what’s fundamental about this. You might say two and a half years, who cares? First of all, I’ll take an extra two and a half years. I’ll take an extra two weeks if I can get it. But two and a half years is a big deal for two reasons. One is, Greg is now showing that you can repeat this and go back not just two and a half years, but five years. I know of people that have reversed their epigenetic clock by 20 years over a year.

Matthew LaPlante (49:09):

They had a measured pretreatment. Right. They’ve gone through the same treatment, the same treatment that Greg used in the study.

David Sinclair (49:17):

Or a similar treatment. Some people. Well, let’s talk about in later episodes how we do that. There are a number of ways now that seem to reverse the age of the body. It’s an amazing thing.

Matthew LaPlante (49:27):

At least according to these biological clocks.

David Sinclair (49:30):

Exactly. Now, we want to now figure out, are they healthier? Do they look younger? So far, anecdotally, the answer is yes. But think about this. This is the second point that’s important. Two and a half years may not be a big deal to some people, some of our audience. But to be immortal, all you have to do is go back one year every birthday.

Matthew LaPlante (49:49):

Oh, well, that’s good. So we’re immortal now. Thank you, David. Yeah. Can we go home now?

David Sinclair (49:54):

Yeah, I think we’re done. We have some work to do. We definitely have work to do, especially when it comes to…

Matthew LaPlante (49:58):

This is going to freak people out because they’re going to say David Sinclair, Harvard University just said that we can be immortal.

David Sinclair (50:04):

Well, there’s no reason why we cannot. There’s no law that says we have to age. And we now are learning not just what causes aging, but how to reset the body so that it’s young again. And we don’t know how many times you can reset the body, but I’m betting that it’s more than once. So what happens in a world where you can reset your age multiple times, maybe hundreds of times, that’s when things get really interesting. And I think when people look at this podcast and listen to it a hundred years from now, they’re going to say, yeah, that was the moment when humanity really changed.

Matthew LaPlante (50:34):

Okay, so let’s kind of encapsulate this all together, summarize. This podcast episode is why we age. So if people want to come away from this and just be able to, like, instead of listening to the episode again and again and again and trying to summarize, because there’s a lot here, let’s hit the points. Why do we age?

David Sinclair (50:58):

Well, we now have an understanding that it’s not just things go wrong. There’s actually a fundamental process, this ticking of the clock, the unspooling of the genes that happens in everything from a tree to a yeast to a worm, mouse and ourselves. That’s a fundamental cause of aging that leads to a lot of things going wrong. There are hallmarks of aging that lead to disease. And we see these in clinics and doctors are trying to treat the end stage of that process, often too late, putting a Band-Aid on a problem.


What I’m saying and what we’ve been discussing is that there’s a layer above all these diseases in the course of aging, and that is the regulators, okay? So the regulators we’ve talked about, we’ve got mTOR that responds to meat and amino acids, NPK, which is blood sugar and energy, and sirtuins, which respond to both of those things and more. And we’ve got those other things in another episode like heat and cold. And what they do is that they’re slowing down all those bad processes. The main one that’s driving all these other bad things and these diseases we call diseases of old age is the X-differentiation process.


So what we really want to do is to get this middle layer to be super potent and slow down and even reverse the aging process. So how do we do that? So now we have this upper layer that’s important. This is the environment. It turns out that most of what regulates this middle protective survival layer is not the genetics that you get from your parents. That’s 20% of the control of aging.

Matthew LaPlante (52:29):

We know that from a twin study of really old data from Denmark.

David Sinclair (52:35):

Mark? Yeah, there’s a study by Christensen et al. 2003 that looked at Danish twins that are genetically identical, but they live different lifestyles, they have different environments. Some smoked, some didn’t, some exercise, some didn’t. And so now we know that even though if you’re genetically identical, 20% of that, it determines your health in later life, slows down aging, but 80% is in your own hands, how you live your life. And that’s the top layer that controls the longevity genes, that controls the X-differentiation and disease process.

Matthew LaPlante (53:06):

Now we’ve got to figure out what to do in that top layer. Like what are the things? This is in our hands. Most of this is in our hands.

David Sinclair (53:12):

Well, a heck of a lot, like 80%, and we now are starting to understand how to live a life to maximize your longevity and slow down that X-differentiation aging process. But we didn’t cover sirtuins in a way that I think we might’ve lost a few people, but the sirtuins, which is the third group of these longevity genes, how did they work? And so three of those seven exist in a nucleus to control that spooling process. So this X-differentiation process actually is due to malfunctions in sirtuins.


And we can maintain their function during old age and even middle age by exercising and dieting and being hungry. Sometimes sirtuins will be activated and we’ll talk about chemical ways to do that later, but then they take care of this, of the packaging of the genome. Whenever I said sirtuins are, SIR stands for silent information regulator.


So what does that mean? Silence is the bundling of the DNA, silencing them. So you don’t want the liver gene on in the brain. Information is the DNA and they regulate it, sirtuins. It’s in the name. And in fact, in the 1990s, that’s why I’ve been working ever since on trying to understand and test my information theory of aging, which is only recently, thanks to the book, become a very popular theory in biology and in fact is now I would say the leading theory of why we age.

Matthew LaPlante (54:35):

And there’s a really good metaphor. We’ve used it before. You’ve used it a lot, but I think it’s worth repeating for this information theory. And ma’am, again, apologies to people who didn’t grow up in the eighties and nineties, but we’re going to go now from cassette tapes to compact discs. CDs.

David Sinclair (54:54):

Yeah. Yeah. Well, these, these were amazing, amazing devices. You could fit about 10 songs on them. And the way that they work is you’ve got digital information in ones and zeros, similar to how DNA is encoded, which is four bases, a chemical ACTG. This digital information is read by a laser and it plays beautiful music. Let’s say you’ve got a symphony with 10 parts to it.


Each cell will play a different combination of those songs, but instead of there being 10 in a cell, there’s 20,000 different genes to play. What I’m saying with aging is that it’s equivalent to having scratches on the CD. So that the reader, which is a laser these days, a blue laser is skipping and playing the wrong songs at the wrong time. And that sounds horrible. That’s a cacophony. Nobody wants to listen to that. That I’m saying is the equivalent of the aging process. And what we’ve been working on for the last 20 years in my lab at Harvard is how do you slow down those scratches and also can you polish the CD so that those beautiful symphonies are played again?

Matthew LaPlante (55:59):

And we’re going to come back to this metaphor, I think probably again and again, there’s sort of a point that we can refer back to when we’re talking about all of these things that we can do to get rid of those scratches, to wipe away that epigenetic junk, to reverse aging.

David Sinclair (56:16):

Right. And then diseases of aging will go away. That’s a big deal. This is, I think, a turning point in medical history that we actually understand what causes those disease fundamentally, not just trying to fix the actual problem when it occurs. I liken this to getting to the edge of a cliff. And you wrote this in the book is that we’ve been far too often working on trying to understand why we’re falling off a cliff at the end of life without even asking the question, what brings us to the edge of that cliff in the first place? Now we finally understand how we get to that cliff and even how to prevent it.

Matthew LaPlante (56:53):

And so at some point, perhaps we don’t have to worry about diseases because we’re going to be so healthy, so young that they’re not going to push us off. They’re going to make us sick maybe. We can treat that.

David Sinclair (57:08):

Well, as we saw with COVID-19, that if you’re young, you can survive. So this is really important. It’s not just about diseases of old age. Diseases throughout life can be prevented and treated by harnessing this middle layer, these protective survival genes, mTOR, NPK, sirtuins, and others. Not just with lifestyle changes, which are pretty easy to implement. We can do that today, but also increasingly with nutrients, with drugs, and supplements.


But it’s a messy world out there. And one of the things that we’re going to do in this podcast in later episodes is to talk about what’s true, what isn’t, what supplements work, what manufacturers you can trust. All of this is to clarify this really untrustworthy world out there and talk about what is known and what is not known and what soon hopefully will be known.

Matthew LaPlante (57:59):

So we’re going to talk a lot about what people can do individually to mitigate aging. But there’s one thing that you said you think we should be doing collectively as a society to address this, to keep not just us individually from that precipice, but to keep us as a people, to keep us as a people from that precipice.

David Sinclair (58:26):

There’s one thing that we’ve been ignoring for centuries, modern medicine doesn’t even think of it. And that is that aging itself is a medical condition. Aging is a disease. And as we’ve been talking about today, and we’ll talk about in later episodes, it’s increasingly a treatable medical condition. So why is that important? Well, the main problem with the way we do what I call whack-a-mole medicine right now is that you wait till you get sick. You go to the doctor, which is often too late, especially when it’s cancer. But even heart disease is hard to reverse currently.


If you go to the doctor, they’ll treat that specific disease and ignoring what got you there in the first place. And you end up having a healthier heart. We have pretty good drugs for blood pressure and heart disease. But that ignores the rest of the body. Our brain still gets old. And this is the worst nightmare for society.


No wonder we’re seeing an increase in dementias because we’re not treating the whole body. But now that we understand that all parts of the body, and essentially all diseases of old age are due to this same underlying process, we can find ways to halt, certainly slow down, halt and reverse this process, not just in one part of the body, but in all tissues and organs so that we can stay young, not just with our cardiovascular system, but our brains as well. And when we do that, that is true longevity. That can get us decades longer, healthier life.

Matthew LaPlante (59:54):

And we can get there together.

David Sinclair (59:54):

Well, that’s what we’re going to talk about. It’s not that difficult to be able to slow down the aging process. It’s not that difficult to measure it. And we’re going to learn how to do that. And this was just the primer. We’re going to get into the more details in later episodes about practical things that people can do every day to be able to maximize their health, their performance, how they look, and ultimately their longevity.

Matthew LaPlante (01:00:16):

Once doctors understand that we can do this, once we all understand that we can do this, it becomes an imperative.

David Sinclair (01:00:21):

Well, I say it’s not just a right to live longer. It’s actually your obligation, your duty to your family. It’s not fair to just abuse your body or neglect it and have them take care of you for 20 years in a nursing home. We owe it to our families to stay as healthy as possible and to society as productive as possible. And let’s say we get another 30 years. Well, another 30 years buys you a chance to start a new career, to visit places, to educate your great grandkids, to have a good time. We are going to have the type of lives that people can only dream of right now.

Matthew LaPlante (01:00:58):

This is going to be fun these next seven episodes.

David Sinclair (01:01:02):

I’m already having a lot of fun. We’re also going to get into some rather interesting research about what works and for the most

Matthew LaPlante (01:01:11):

part what doesn’t. And that’s going to be, I think, challenging also to a lot of people who want a very quick and easy solution or want to believe what they assume works.

David Sinclair (01:01:26):

Well, there are a lot of myths out there. Let’s rattle some off. Telomeres, antioxidants, these things, we’re going to get into it, but there are so many things that have become myths out there that do very little for your longevity, but there are some things that actually do work right now and things that are just around the corner that will blow everybody’s minds.

Matthew LaPlante (01:01:47):

And the next episode we’re going to be talking specifically about dieting and fasting and we don’t want to give that away, but that’s up next, right?

David Sinclair (01:01:56):

It is. And so we’ll see you in a week. We’re going to round this out with a thanks. If you’ve enjoyed the show, you can subscribe either on Apple, Spotify, or YouTube. And on Apple, you can leave up to a five-star rating. Another way of supporting us is to support our sponsors who I mentioned earlier in the show. And finally, another great way to support us is through Patreon. We have a Patreon website at slash David Sinclair. Thanks again for joining us. We hope to see you next week.

Episode Info

In this episode, Dr. David Sinclair and co-host Matthew LaPlante discuss why we age. In doing so, they discuss organisms that have extreme longevity, the genes that control aging (mTOR, AMPK, Sirtuins), the role of sirtuin proteins as epigenetic regulators of aging, the process of "ex-differentiation" in which cells begin to lose their identity, and how all of this makes up the "Information Theory of Aging", and the difference between "biological age" and "chronological age" and how we can measure biological age through DNA methylation clocks.

Thank you to our sponsors:

Our Patreon page: 

Lifespan book:

Dr. David Sinclair Social:

To stay up to date with David's work to democratize biological age testing and insights, visit

Matthew LaPlante's Social:


(00:00:00) Introduction

(00:03:14) Goal of the Lifespan Podcast

(00:07:11) Acknowledgement of Sponsors

(00:10:45) Aging is a Controllable Process that can be Slowed & Reversed

(00:16:42) Organisms with Extreme Longevity

(00:21:47) Genes that Regulate Aging: mTOR, AMPK, Sirtuins

(00:21:55) mTOR & Rapamycin

(00:24:33) AMP-activated protein kinase (AMPK) & Metformin

(00:30:57) Sirtuin Proteins as Epigenetic Regulators of Aging

(00:35:33) Ex-Differentiation

(00:43:30) Measuring Aging - Biological Age vs. Chronological Age

(00:49:30) "No Law That Says We Have To Age"

(00:50:33) Episode Summary & Key Takeaways - Why Do We Age?

(00:54:00) Information Theory of Aging

(00:57:59) Aging is a Medical Condition

(01:01:00) Aging Myths - Telomeres & Antioxidants

(01:01:55) Options for Subscription and Support

For the full show notes, including the peer-reviewed studies, visit the Lifespan podcast website.

Please note that Lifespan with Dr. David Sinclair is distinct from Dr. Sinclair's teaching and research roles at Harvard Medical School. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Lifespan with Dr. David Sinclair podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.

Title Card Photo Credit: Mike Blabac

Special thanks to our research assistants, Adiv Johnson & Sarah Ryan.